139 related articles for article (PubMed ID: 30676667)
1. Identification of epithelial-specific ETS-1 (ESE-1) as a tumor suppressor and molecular target of green tea compound, EGCG.
Ha T; Lee J; Lou Z; Lee BS; Kim CH; Lee SH
Mol Carcinog; 2019 Jun; 58(6):922-932. PubMed ID: 30676667
[TBL] [Abstract][Full Text] [Related]
2. The ETS transcription factor ESE-1 transforms MCF-12A human mammary epithelial cells via a novel cytoplasmic mechanism.
Prescott JD; Koto KS; Singh M; Gutierrez-Hartmann A
Mol Cell Biol; 2004 Jun; 24(12):5548-64. PubMed ID: 15169914
[TBL] [Abstract][Full Text] [Related]
3. Peracetylated (-)-epigallocatechin-3-gallate (AcEGCG) potently suppresses dextran sulfate sodium-induced colitis and colon tumorigenesis in mice.
Chiou YS; Ma NJ; Sang S; Ho CT; Wang YJ; Pan MH
J Agric Food Chem; 2012 Apr; 60(13):3441-51. PubMed ID: 22409325
[TBL] [Abstract][Full Text] [Related]
4. (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells.
Shimizu M; Deguchi A; Lim JT; Moriwaki H; Kopelovich L; Weinstein IB
Clin Cancer Res; 2005 Apr; 11(7):2735-46. PubMed ID: 15814656
[TBL] [Abstract][Full Text] [Related]
5. Mapping of ESE-1 subdomains required to initiate mammary epithelial cell transformation via a cytoplasmic mechanism.
Prescott JD; Poczobutt JM; Tentler JJ; Walker DM; Gutierrez-Hartmann A
Mol Cancer; 2011 Aug; 10():103. PubMed ID: 21871131
[TBL] [Abstract][Full Text] [Related]
6. Structural shift of gut microbiota during chemo-preventive effects of epigallocatechin gallate on colorectal carcinogenesis in mice.
Wang X; Ye T; Chen WJ; Lv Y; Hao Z; Chen J; Zhao JY; Wang HP; Cai YK
World J Gastroenterol; 2017 Dec; 23(46):8128-8139. PubMed ID: 29290650
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of OCT4 by the ETS transcription factor ESE-1 in NCCIT human embryonic carcinoma cells.
Park SW; Do HJ; Ha WT; Han MH; Yang HM; Lee SH; Song H; Kim NH; Kim JH
Biochem Biophys Res Commun; 2014 Jul; 450(2):984-90. PubMed ID: 24971534
[TBL] [Abstract][Full Text] [Related]
8. Epithelium-specific ETS transcription factor-1 regulates NANOG expression and inhibits NANOG-induced proliferation of human embryonic carcinoma cells.
Park SW; Do HJ; Choi W; Lim DS; Park KH; Kim JH
Biochimie; 2021 Jul; 186():33-42. PubMed ID: 33865902
[TBL] [Abstract][Full Text] [Related]
9. The uncovering of ESE-1 in human neutrophils: implication of its role in neutrophil function and survival.
Lee CM; Gupta S; Parodo J; Wu J; Marshall JC; Hu J
Genes Immun; 2015; 16(5):356-61. PubMed ID: 25906252
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effects of (-)-epigallocatechin gallate with sulindac against colon carcinogenesis of rats treated with azoxymethane.
Ohishi T; Kishimoto Y; Miura N; Shiota G; Kohri T; Hara Y; Hasegawa J; Isemura M
Cancer Lett; 2002 Mar; 177(1):49-56. PubMed ID: 11809530
[TBL] [Abstract][Full Text] [Related]
11. Epigallocatechin-3-gallate suppresses hemin-aggravated colon carcinogenesis through Nrf2-inhibited mitochondrial reactive oxygen species accumulation.
Seok JH; Kim DH; Kim HJ; Jo HH; Kim EY; Jeong JH; Park YS; Lee SH; Kim DJ; Nam SY; Lee BJ; Lee HJ
J Vet Sci; 2022 Sep; 23(5):e74. PubMed ID: 36174978
[TBL] [Abstract][Full Text] [Related]
12. Epigallocatechin-3-gallate suppresses the expression of HSP70 and HSP90 and exhibits anti-tumor activity in vitro and in vivo.
Tran PL; Kim SA; Choi HS; Yoon JH; Ahn SG
BMC Cancer; 2010 Jun; 10():276. PubMed ID: 20537126
[TBL] [Abstract][Full Text] [Related]
13. ESE-1 Knockdown Attenuates Growth in Trastuzumab-resistant HER2
Kar A; Liu B; Gutierrez-Hartmann A
Anticancer Res; 2017 Dec; 37(12):6583-6591. PubMed ID: 29187433
[TBL] [Abstract][Full Text] [Related]
14. ESE-3 transcription factor is involved in the expression of death receptor (DR)-5 through putative Ets sites.
Lim JH; Cho JY; Park YB; Park JW; Kwon TK
Biochem Biophys Res Commun; 2006 Nov; 350(3):736-41. PubMed ID: 17027647
[TBL] [Abstract][Full Text] [Related]
15. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
[TBL] [Abstract][Full Text] [Related]
16. Epigallocatechin gallate hinders human hepatoma and colon cancer sphere formation.
Wubetu GY; Shimada M; Morine Y; Ikemoto T; Ishikawa D; Iwahashi S; Yamada S; Saito Y; Arakawa Y; Imura S
J Gastroenterol Hepatol; 2016 Jan; 31(1):256-64. PubMed ID: 26241688
[TBL] [Abstract][Full Text] [Related]
17. SPDEF functions as a colorectal tumor suppressor by inhibiting β-catenin activity.
Noah TK; Lo YH; Price A; Chen G; King E; Washington MK; Aronow BJ; Shroyer NF
Gastroenterology; 2013 May; 144(5):1012-1023.e6. PubMed ID: 23376423
[TBL] [Abstract][Full Text] [Related]
18. WD-repeat protein WDR13 is a novel transcriptional regulator of c-Jun and modulates intestinal homeostasis in mice.
Singh VP; Katta S; Kumar S
BMC Cancer; 2017 Feb; 17(1):148. PubMed ID: 28222755
[TBL] [Abstract][Full Text] [Related]
19. PTEN/AKT/mTOR signaling mediates anticancer effects of epigallocatechin‑3‑gallate in ovarian cancer.
Qin J; Fu M; Wang J; Huang F; Liu H; Huangfu M; Yu D; Liu H; Li X; Guan X; Chen X
Oncol Rep; 2020 Jun; 43(6):1885-1896. PubMed ID: 32236585
[TBL] [Abstract][Full Text] [Related]
20. The Effect of Different Treatments of (-)-Epigallocatechin-3-Gallate on Colorectal Carcinoma Cell Lines.
Ding YP; Gao ZL; Chen BC; Rakariyatham K; Suo HY; Tong HR; Xiao H
Nutr Cancer; 2018 Oct; 70(7):1126-1136. PubMed ID: 30513211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
